News Kali, Inc.

Equities

KALY

US4833801016

Market Closed - OTC Markets Other stock markets 09:30:00 2024-05-08 EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2020	PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc..	CI
2020	PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc..	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alkame : PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand	21-05-19	AQ
Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs	21-05-12	AQ
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End	21-05-06	AQ
Kali : PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment	21-04-13	AQ
PAOG Announces Opportunity To Expand CBD Pharmaceutical Research	21-04-13	NE
Alkame : PAO Group, Inc. Has Two CBD-Based Therapeutics In Play; Planned Launch For One In September Puts Catalyst In Play	21-04-07	AQ
Alkame : Catalyst From PAO Group Inc.'s CBD-Based Therapeutics Program In Play; Accelerates RespRx R&D Program	21-03-24	AQ
Puration Inc :.'s Stock Is In Bull Market Mode; Acquisitions And Strong Revenues Kick Off Big Start To 2021	21-02-03	AQ
PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow	21-01-13	NE
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021	21-01-12	NE
PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2020	21-01-11	NE
PAOG Confirms Q4 2020 Revenue from Cannabis Asset Acquisition	21-01-08	NE
PAOG Expects to Report First Post Acquisition Revenue in Q4 2020	20-12-22	NE
Kali : PAOG Announces CRO Agreement To Advance Respiratory Cannabis Treatment Through Regulatory Approval	20-10-23	PR
Kali : PAOG - New Independent CBD Research Appears To Support PAOG RespRx Research	20-10-20	PR
Kali : PAOG FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday	20-10-20	PR
PAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp Awareness	20-10-16	NE
PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND	20-10-01	NE
PAOG Cannabis Pharmaceutical Research Initiative Gains New Traction	20-09-30	NE
PAOG Expands Cannabis Pharma Treatment Research	20-09-24	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kali, Inc.

Equities

KALY

US4833801016

Summary

Filters